News

PontAlexandreIII-311184-1408685660777.gif

Pictures from Paris

Take a pictorial tour of Paris with the editors of Applied Clinical Trials

Dehecq-311130-1408685728069.gif

Program Co-Chairs Iman Barilero, Johnson & Johnson PRD, and Marie Dray, International Regulatory Affairs Group USA, opened the first plenary session with introductions, sharing their vision of what the 18th Annual DIA EuroMeeting is all about: continuing themes throughout the meeting, including pediatrics, advanced therapies, technology platform, pharmacovigilance, risk management planning, and the involvement of patient groups.

The first keynote speaker Georgette Lalis, Head of DG Enterprise and Industry for the European Commission, began her presentation "The Decline of Pharmaceutical Innovation in Europe" by acknowledging, "Innovation is the life blood of the pharmaceutical industry." She added that regulators must be equally innovative, playing a key role in the growth of R&D development in Europe, noting that Europe is facing massive health threats and the health system is under distress.

tower160-310913-1408686086755.gif

Welcome

Welcome to the Applied Clinical Trials eShow Daily coming from the floor of the DIA 18th Annual EuroMeeting in Paris, France.

Graduates Session

09:00-12:30 Graduates Session With Speakers from the DIA and National Health Authorities

i3_t-310803-1408686271985.jpg

eShowcase

Tools for Clinical Trials Professionals

i1-306509-1408680354575.jpg

EShowcase

Tools for Clinical Trials Professionals

United BioSource Corporation (UBC) today announced the acquisition of MetaWorks, Inc., a leading provider of systematic reviews and meta-analyses to inform development, marketing, and regulatory decision-making regarding health care products and services.

Key to improving R&D productivity is the willingness of drug developers to use new discovery tools, such as pharmacogenomics, to accelerate the pace of translating basic research into viable drug candidates, and the aggressive management of clinical trials, through advanced data analysis and outsourcing, to lower cost sites around the world, said Tufts CSDD Director Kenneth I Kaitin.